Epratuzumab Tesirine

Product Description: Epratuzumab Tesirine (ADCT-602) is a novel CD22-targeted ADC. Epratuzumab Tesirine contains a PBD dimer and a payload SG3249[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Francesca Zammarchi, et al. ADCT-602, a Novel PBD Dimer-containing Antibody-Drug Conjugate for Treating CD22-positive Hematologic Malignancies. Mol Cancer Ther. 2024 Apr 2;23(4):520-531.

Molecular Weight: N/A

Research Area: Cancer

Target: Antibody-Drug Conjugates (ADCs)

• SKU: MEXHY-164730-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-164730-5
• Package Unit: 5 mg
• Quantity Unit: STK